| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.8M | +265.2% |
| R&D Expense | $5.0M | -40.7% |
| SG&A Expense | $9.4M | +20.5% |
| Operating Income | -$10.6M | +31.1% |
| Income Tax | $0 | — |
| Net Income | -$10.6M | +29.1% |
| EPS (Basic) | -$3.46 | +55.6% |
| EPS (Diluted) | -$3.46 | +55.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $12.1M | -35.2% |
| Accounts Receivable | $99K | -40.0% |
| Inventory | $61K | +0.0% |
| Current Assets | $13.5M | -37.7% |
| Total Assets | $19.1M | -30.0% |
| Current Liabilities | $1.2M | -47.0% |
| Total Liabilities | $5.7M | -19.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$9.7M | +33.4% |
| Capital Expenditures | $216K | -10.4% |
| Investing Cash Flow | -$216K | +10.4% |
| Financing Cash Flow | $3.3M | -87.7% |
| Free Cash Flow | -$9.9M | +33.0% |
| Stockholders' Equity |
| $14.4M |
| -32.0% |